Data presented today at the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD) show that R…
Ryzodeg
FDA Delays Review of Novo Nordisk’s New Drug Applications for Tresiba and Ryzodeg
The U.S. FDA issued a Complete Response Letter regarding the New Drug Applications for Tresiba (insulin degludec) and Ry…
Novo Nordisk’s New Insulins, Tresiba and Ryzodeg, Approved by EU
The European Commission has granted Novo Nordisk marketing authorizations for Tresiba (insulin degludec) and Ryzodeg (in…
Novo Nordisk’s Combination Insulin Ryzodeg Approved in Japan
The Japanese Ministry of Health, Labor and Welfare has approved Novo Nordisk's new combination insulin, Ryzodeg, for the…
